regeneron 23andme - Search News

Order byBest matchMost fresh

Regeneron Pharmaceuticals to buy 23andMe and its data

Pharmaceutical company Regeneron buying 23andMe for $256 million

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase Monday.

Continue reading

· 6h · on MSN

· 1d · on MSN

Regeneron Pharmaceuticals to buy 23andMe for $256M

· 22h · on MSN

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

23andMe to Be Bought by Biotech Company for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.

Continue reading

23andMe Sold To Biotechnology Company For $256 Million

Regeneron agrees to buy bankrupt 23andMe

A drug developer is buying 23andMe - what does that mean for your DNA data?

Regeneron vows to prioritize the privacy, security, and ethical use of customer data.

Continue reading

23andMe bought by Regeneron in court auction

Biotechnology Company Regeneron to Buy 23andMe for $256 million

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to close in Q3 2025

Daily Voice on MSN6h

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, promising to honor existing privacy protections and continue consumer services with no changes.

Regeneron makes another deal — This one about AI

Regeneron has been busy, with two health tech deals announced this week: One is about genetic data and one about AI. Both of them are about developing and selling drugs, really.

Explore more